About Coiled-coil domain-containing protein 71
Coiled-coil domain-containing protein 71 (CCDC71) is a protein
from Homo sapiens identified by UniProt accession
Q8IV32, 467 residues long.
MolForge cross-references it against 0 known binders and
47 disease associations.
Target properties
| Protein name | Coiled-coil domain-containing protein 71 |
| UniProt accession | Q8IV32 |
| Gene | CCDC71 |
| Organism | Homo sapiens |
| Length | 467 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (47)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.37
- fat body mass · score 0.15
- body fat percentage · score 0.14
- insomnia measurement · score 0.14
- Irritability · score 0.13
- irritability measurement · score 0.12
- age at first birth measurement · score 0.12
- unipolar depression · score 0.11
- body mass index · score 0.09
- body weights and measures · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8IV32-F1 | alphafold | PREDICTED | 52.48 | — |
Amino-acid sequence (467 residues)
MSVVVQHVEE KAVHSWSRIS TAGKKALEEA LLVFNPMSQD LSATEAQLVA FLQGLRDDGF QPTILRSGDV YGYSSCTANP PSQTKLQARA PNPTATSPPA SAPRTAMRLP AGRATLLPMP LSGRLAKAST PALAKHATTN LLLSSLKQSS ASHARGAAVG FPTHLYPGVY PAMRLSVVLE ALVPLKTPMP CLGAKHKAQS LQLSLADSPL KLRKSSGKGP GNPRPKAPRK TTSKGPKCLT RKGPGAGPRR GSGHQSKTNR ATGSPSVRRM KGGSALGTKT AQAKVARTLA KAARAQAKVA RTQAKAAKAR AKAKAAQVKA KAKAKAAQVK AKAKVMAAWA KAKAKAKAVR AKAKVARTQP RGRGRPKGSA KARTTRKGQK NRPETVGQKR KRAEEAKDLP PKKRTRLGPR SPKAWLGPGT AKLLKFRAIK VDRRSSDDEV RQRAQRILRV NLSPVIRLQP LLPYSAV
Explore Coiled-coil domain-containing protein 71 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets